These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36628250)

  • 1. Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.
    Li X; Abdel-Maksoud MA; Iqbal I; Mubarak A; Farrag MA; Haris M; Alghamdi S; Ain QU; Almekhlafi S
    Am J Transl Res; 2022; 14(12):8843-8861. PubMed ID: 36628250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
    Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
    Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
    Xue H; Sun Z; Wu W; Du D; Liao S
    Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
    Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
    Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
    Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
    Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
    Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
    J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
    Li X; Li M; Zhao T; Zhang J
    Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
    Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
    J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 11. Identifying hub genes for chemo-radiotherapy sensitivity in cervical cancer: a bi-dataset in silico analysis.
    Wang Y; Ouyang Y; Cao X; Cai Q
    Discov Oncol; 2024 Sep; 15(1):434. PubMed ID: 39264467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
    Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
    Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
    Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
    Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
    Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
    J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
    Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
    Front Genet; 2020; 11():575762. PubMed ID: 33505422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.